Crossmark

Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain

Published Online: 2021-09-14

Published Print: 2021-10

Authors

Alonso-Perez, Enrique https://orcid.org/0000-0002-0228-5084
Forné, Carles https://orcid.org/0000-0002-8133-3274
Soro, Marco

Valls, Marta

Manganelli, Anton-Giulio https://orcid.org/0000-0003-1787-7215
Valdivielso, Jose M. https://orcid.org/0000-0003-1343-0184
Funding

Funding for this research was provided by:

Vifor Pharma
License Information

Text and Data Mining valid from 2021-09-14

Version of Record valid from 2021-09-14
More Information

Article History

Received: 14 June 2021

Accepted: 12 August 2021

First Online: 14 September 2021

Document is current